16.01.2014 • NewsBASF Venture CapitalDede WillamsEvonik

Evonik Venture Capital Invests in FRX Polymers

With a $2.5 million cash injection, the venture capital fund of Germany's Evonik has led a $12 million series C financing round in U.S.-based FRX Polymers. Under the Nofia trademark, the company headquartered at Chelmsford, Massachusetts, manufactures and markets what it says is an environmentally friendly family of non-halogenated flame retardant plastics and oligomers based on polyphosphonate.

Evonik's funds injection coincided with the opening of FRX's first industrial-scale flame retardant polymer plant at Antwerp, Belgium. The U.S. company already operates two pilot plants at Chelmsford and another in Switzerland. Other investors in the series C round include Capricorn Venture Partners, DB Masdar, SAM Private Equity, BASF Venture Capital, Israel Cleantech Ventures, and a western Canadian syndicate. In its last round of fundraising,Series B, in March 2012, FRX took in $26.7 million.

The FRX polymers, designed to replace brominated FR systems, are used in a wide variety of electronics, building & construction, fiber, and transportation applications. The Nofia polyphosphonates have little impact on the inherent mechanical properties of the host resin, according to the company's CEO, Marc Lebel.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.